Functional and morphological changes of the retinal vessels in Alzheimer's disease and mild cognitive impairment.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
11 01 2019
11 01 2019
Historique:
received:
11
05
2018
accepted:
04
12
2018
entrez:
13
1
2019
pubmed:
13
1
2019
medline:
21
1
2020
Statut:
epublish
Résumé
Imaging and histopathological studies have demonstrated that structural changes of the retina affect subjects with Alzheimer's disease (AD) or mild cognitive impairment (MCI). The aim of this study was to quantitatively investigate the retinal vessels in these disorders, using dynamic vessel analyzer (DVA) and optical coherence tomography angiography (OCTA) analysis. Twelve subjects with AD, 12 subjects with MCI, and 32 gender- and age-matched controls were prospectively enrolled. Mean ± SD age was 72.9 ± 7.2 years in the AD group, 76.3 ± 6.9 years in the MCI group, and 71.6 ± 5.9 years in the control group (p = 0.104). In the DVA dynamic analysis, the arterial dilation was decreased in the AD group (0.77 ± 2.06%), in the comparison with the control group (3.53 ± 1.25%, p = 0.002). The reaction amplitude was decreased both in AD (0.21 ± 1.80%, <0.0001) and MCI (2.29 ± 1.81%, p = 0.048) subjects, compared with controls (3.86 ± 1.94%). OCTA variables did not differ among groups. In the Pearson correlation analysis, amyloid β level in the cerebrospinal fluid was directly correlated with the arterial dilation (R = 0.441, p = 0.040) and reaction amplitude (R = 0.580, p = 0.005). This study demonstrate that Alzheimer's and MCI subjects are characterized by a significant impairment of the retinal neurovascular coupling. This impairment is inversely correlated with the level of amyloid β in the cerebrospinal fluid.
Identifiants
pubmed: 30635610
doi: 10.1038/s41598-018-37271-6
pii: 10.1038/s41598-018-37271-6
pmc: PMC6329813
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
63Références
Br J Ophthalmol. 2018 Feb;102(2):233-237
pubmed: 28600299
Lancet Neurol. 2016 Aug;15(9):934-943
pubmed: 27312738
Brain Res Brain Res Rev. 2000 Dec;34(3):119-36
pubmed: 11113503
Alzheimers Dement. 2011 May;7(3):270-9
pubmed: 21514249
Graefes Arch Clin Exp Ophthalmol. 2004 May;242(5):377-92
pubmed: 14770317
Retina. 2019 Jun;39(6):1216-1224
pubmed: 29474304
Cerebrovasc Dis. 2002;13 Suppl 2:48-52
pubmed: 11901243
Alzheimers Dement (Amst). 2017 Nov 06;10:49-55
pubmed: 29201990
Lancet. 2006 Jul 29;368(9533):387-403
pubmed: 16876668
J Neuropathol Exp Neurol. 2013 Jun;72(6):462-71
pubmed: 23656989
Am J Ophthalmol. 1987 Aug 15;104(2):113-20
pubmed: 3618708
J Alzheimers Dis. 2015;45(1):45-56
pubmed: 25428254
Arch Neurol. 2001 Mar;58(3):397-405
pubmed: 11255443
Korean J Ophthalmol. 2017 Dec;31(6):548-556
pubmed: 29022297
Folia Neuropathol. 2006;44(1):17-23
pubmed: 16565927
Lancet Neurol. 2006 Mar;5(3):228-34
pubmed: 16488378
J Cereb Blood Flow Metab. 2015 Jul;35(7):1055-68
pubmed: 25899298
Invest Ophthalmol Vis Sci. 2007 May;48(5):2285-9
pubmed: 17460292
Retina. 2015 Oct;35(10):2052-9
pubmed: 25932556
Br J Ophthalmol. 2017 Sep;101(9):1193-1200
pubmed: 28057649
Neuroreport. 2011 Aug 24;22(12):623-7
pubmed: 21734608
Arch Pathol Lab Med. 2004 Jan;128(1):32-8
pubmed: 14692815
Int J Retina Vitreous. 2016 Oct 17;2:24
pubmed: 27847642
Acta Diabetol. 2017 Jan;54(1):39-43
pubmed: 27600440
Arch Neurol. 1999 Mar;56(3):303-8
pubmed: 10190820
Ophthalmology. 1990 Jan;97(1):9-17
pubmed: 2314849
Am J Ophthalmol. 2015 Jul;160(1):45-52.e1
pubmed: 25896458
Graefes Arch Clin Exp Ophthalmol. 2017 Jun;255(6):1079-1083
pubmed: 28190191
Invest Ophthalmol Vis Sci. 2007 May;48(5):1995-2000
pubmed: 17460252
JAMA Ophthalmol. 2017 Oct 1;135(10):1092-1098
pubmed: 28910435
Atherosclerosis. 2002 Dec;165(2):353-9
pubmed: 12417287
Clin Exp Ophthalmol. 2015 Mar;43(2):145-51
pubmed: 24995484
Ann N Y Acad Sci. 2002 Nov;977:9-23
pubmed: 12480729
Neurobiol Aging. 1996 May-Jun;17(3):377-84
pubmed: 8725899
Invest Ophthalmol Vis Sci. 2013 Sep 05;54(9):5953-8
pubmed: 23920375
Invest Ophthalmol Vis Sci. 2017 Apr 1;58(4):2063-2069
pubmed: 28388703
Graefes Arch Clin Exp Ophthalmol. 2016 May;254(5):827-34
pubmed: 26245340
Invest Ophthalmol Vis Sci. 2016 Oct 1;57(13):5780-5787
pubmed: 27792812
Arch Neurol. 2009 Mar;66(3):382-9
pubmed: 19273758
N Engl J Med. 2012 Aug 30;367(9):795-804
pubmed: 22784036
J Anat. 2005 Apr;206(4):319-48
pubmed: 15817102
Lancet. 1997 Jan 18;349(9046):151-4
pubmed: 9111537
Ann Neurol. 1993 Mar;33(3):248-57
pubmed: 8498808
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Clin Chem. 2001 Oct;47(10):1776-81
pubmed: 11568086
Br J Ophthalmol. 2014 Oct;98(10):1368-73
pubmed: 24831719
JAMA Ophthalmol. 2017 Nov 1;135(11):1197-1204
pubmed: 28983552
Alzheimers Dement. 2009 Jul;5(4):340-7
pubmed: 19560104
Alzheimers Dement. 2011 May;7(3):263-9
pubmed: 21514250
Dev Ophthalmol. 2016;56:1-5
pubmed: 27022921
Sci Rep. 2017 Oct 10;7(1):12906
pubmed: 29018233
Br J Ophthalmol. 2018 Sep;102(9):1192-1198
pubmed: 29363531
N Engl J Med. 1986 Aug 21;315(8):485-7
pubmed: 3736630
Alzheimers Dement. 2015 Jun;11(6):710-7
pubmed: 25510382